Comprehensive Cancer Centers of Nevada Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Comprehensive Cancer Centers of Nevada's estimated annual revenue is currently $110.7M per year.(i)
  • Comprehensive Cancer Centers of Nevada's estimated revenue per employee is $337,500

Employee Data

  • Comprehensive Cancer Centers of Nevada has 328 Employees.(i)
  • Comprehensive Cancer Centers of Nevada grew their employee count by 15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$539.3M214010%N/AN/A
#2
$2328.2M15-40%$4.9MN/A
Add Company

Comprehensive Cancer Centers of Nevada (CCCN) is the award-winning multidisciplinary oncology group comprising medical oncology, hematology, radiation oncology, breast surgery and pulmonary medicine, with 17 treatment centers and offices throughout Southern Nevada and Arizona. CCCN has provided oncology services to Southern Nevada residents and visitors for more than 40 years. The practice's specialized physician and nursing staff offers sophisticated diagnostic tools, the latest advances in cancer treatment, a full range of innovative, exclusive services and research-based care in a supportive and caring environment. In order to provide patients the most progressive and effective cancer treatments, CCCN expanded its clinical research program by partnering with some of the world's most recognizable research and cancer-fighting organizations. In 1995, CCCN physicians became part of The US Oncology Network, one of the nation's largest networks of community-based oncology physicians dedicated to advancing cancer care in America. In 2015, CCCN added a clinical affiliation agreement with University of Southern California (USC) Norris Comprehensive Cancer Center, a prestigious academic cancer center and one of the original eight comprehensive cancer centers in the United States, as designated by the National Cancer Institute (NCI). The affiliation agreement between CCCN and USC builds on the organizations' more than 80 years of combined cancer expertise to further enhance patients' quality of care, access to clinical research studies as well as access to procedures currently not offered in Southern Nevada. Today, CCCN participates in more than 170 Phase I, Phase II and Phase III clinical research studies each year, and has helped develop 55 FDA approved cancer therapies including the recent approvals for Provenge, Xofigo and Hercepin. Medical Oncology, Hematology, Radiation Oncology, Breast Surgery, Pulmonary Medicine, Clinical Research, Cancer Treatment, Diagnostic Imaging

keywords:N/A

N/A

Total Funding

328

Number of Employees

$110.7M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Comprehensive Cancer Centers of Nevada News

2022-04-17 - Banner Health to build new hospital in Buckeye New facility ...

PHOENIX (April 19, 2022) – Banner Health is planning construction for a new, comprehensive medical center in the Southwest Valley of metro...

2022-04-17 - University Hospitals and Cleveland Clinic Join Forces to Prevent Substance Misuse and Overdose Deaths by Hosting Drug Take Back Day on April 30

“We are proud to be working with University Hospitals on a variety of ... part of the NCI-designated Case Comprehensive Cancer Center.

2022-04-06 - Patients return to doctors' offices in large numbers as pandemic eases

Moreover, healthcare facilities that have had staff departures during ... the Ohio State University Comprehensive Cancer Center in Columbus.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A330-14%N/A
#2
$91.3M332-1%N/A
#3
$112.7M334-11%N/A
#4
$119.1M3533%N/A
#5
$123.5M366-6%N/A